uniQure N.V.
$44.00
-$0.09 (-0.20%)
$43.56Day Range$44.52
Key Statistics
Market Cap
$3.06B
Shares Outstanding
69.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 5, 2014
Round Lot
100
Locale
US
Trading Data
Day Open
$44.40
Day High
$44.52
Day Low
$43.56
Volume
2.10M
VWAP
$44.00
Prev Close
$44.09
Transactions
--
Acc. Volume
--
About uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
PHARMACEUTICAL PREPARATIONSSIC 2834221 employeesPAASHEUVELWEG 25A, AMSTERDAM, 1105 BP1-339-970-7000IPO Feb 5, 2014US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001590560
- Ticker Root
- QURE
- SIC Code
- 2834
About uniQure N.V. (QURE) Stock
uniQure N.V. (QURE) closed the 2026-09-18 session at $44.00, down 0.20% versus the previous close (-0.09). The stock opened at $44.40 and traded between $43.56 and $44.52 during that session. Session trading volume was 2.1M shares. The volume-weighted average price (VWAP) is $44.00.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
uniQure N.V. has a market capitalization of $3.06 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. QURE is listed on the XNAS exchange. The company employs approximately 221 people. The recorded listing date is 2014-02-05.
On this page you can find market QURE stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.